Clinical trial
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
NCT05318092 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
- Lead sponsor
- Angiodynamics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 19, 2022
- Completion date
- January 4, 2024
- Enrollment
- 122 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
acute pulmonary embolism, pulmonary embolism